Cell Therapy Instrument Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)

Cell Therapy Instrument Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Consumables, Equipment, Systems and Software); Cell Type (Human Cells, and Animal Cells); Process (Cell Processing, Process Monitoring and Quality Control, Cell Preservation, Distribution, and Handling); End User (Research Institutes, Life Science Research Companies, and Other End Users), and Geography

  • Report Code : TIPRE00003481
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Cell Therapy Instruments Market Size, Growth, Share 2021-2031

Buy Now

The cell therapy instrument market was valued at US$ 15.15 billion in 2021 and is expected to reach US$ 59.98 billion by 2031. The market is expected to register a CAGR of 15.4% in 2023–2031. Shift toward automated manufacturing will likely remain a key cell therapy instrument market trend.

Cell Therapy Instrument Market Analysis

Cell therapy is when living and intact cells are injected, implanted, or grafted into the patient's body. For instance, a person with cancer is injected with T cells during their course of immunotherapy. Delivery of cell therapy instruments ranges from injections to surgical implantation using special devices. Cell therapy has applications in a large number of disorders. The most important diseases of the nervous system are cancer. Other applications include cardiac conditions (myocardial infarction and heart failure), diabetes mellitus, bones and joints, genetic disorders, and wounds of the skin and soft tissues.

Cell Therapy Instrument Market Overview

One of the most promising methods for treating cancer is chimeric antigen receptor (CAR) T-cell therapy, and every year, an enormous number of pre-clinical and clinical trials are conducted to increase its application. After decades of research, CAR-T cell therapy will inevitably expand. In addition to autologous and allogeneic products, new in-vivo CAR-T cell gene therapies and efficacy in indications other than hematologic malignancies will also be investigated in the future of cellular therapies. 

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Cell Therapy Instrument Market: Strategic Insights

Cell Therapy Instrument Market

  • CAGR (2023 - 2031)
    15.4%
  • Market Size 2021
    US$ 15.15 Billion
  • Market Size 2031
    US$ 59.98 Billion

Market Dynamics

GROWTH DRIVERS
  • Increasing Developments in Cell Therapy Manufacturing
FUTURE TRENDS
  • Shift toward automated manufacturing
OPPORTUNITIES
  • Growth Opportunities in Developing Regions

Key Players

  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • Lonza
  • Cytiva (GE Healthcare Life Sciences)
  • Terumo Corporation
  • BD
  • Miltenyi Biotec
  • STEMCELL Technologies Inc.
  • Sartorius AG
  • Danaher Corporation (Beckman Coulter Inc.)

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product
  • Consumables
  • Equipment
  • Systems and Software; Cell Type
Cell Type
  • Human Cells
  • Animal Cells
Process
  • Cell Processing
  • Process Monitoring and Quality Control
  • Cell Preservation
  • Distribution
  • Handling
End User
  • Research Institutes
  • Life Science Research Companies
  • Other End Users
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Cell Therapy Instrument Market Drivers and Opportunities

Increasing Developments in Cell Therapy Manufacturing

The increasing research activities in cell therapy have led to extraordinary therapeutic developments in cell therapy instruments to treat genetic disorders and improve the immune system efficiently. Various market players provide consumables such as reagent kits and enzymes, and many companies offer instruments, equipment, and software to conduct a wide range of cell therapy processes.

Equipment use is important for producing cell therapies such as T cells, HSC, MSC, PSC, and NSC. These cell therapy products are derived from human or animal cells and thus require safe conditions from contamination. Thus, the instruments used for cell therapies help prevent contamination and allow scaling up the production. For instance, companies such as Corning Incorporated, Hitachi Chemical Advanced Therapeutics Solutions, LLC, Cytiva (General Electric Company), Thermo Fisher Scientific Inc., Invetech, and Miltenyi Biotec have introduced various instruments and consumables for cell therapy.

Growth Opportunities in Developing Regions– An Opportunity in the Cell Therapy Instruments Market

The biotechnology sector in Asia Pacific and Middle East is growing rapidly with the support of heavy investments and strategic developments among private and public organizations with countries in North American and European regions. For instance, in December 2019, Astellas Pharma Inc (Japan) signed an agreement to acquire Audentes Therapeutics Inc., a gene therapy company, for US$ 3 billion. Similarly, in November 2019, Fujifilm planned to invest ~US$ 120 million (13 billion yen) in gene therapy as a part of contract development and manufacturing segment of the organization. Also, the Japan Pharmaceutical Medical Device Agency (PMDA) approved two gene therapy products. The products were approved simultaneously under Sakigake designation, which is equivalent to the FDA breakthrough therapy designation and the EMA Priority Medicine (PRIME) designation and is expected to approve at least one therapy per year. Such strategic developments by the domestic players in the Asian countries for cell therapy domain are likely to increase demand for cell therapy instruments in coming future.

Cell Therapy Instrument Market Report Segmentation Analysis

Key segments that contributed to the derivation of the cell therapy instrument market analysis are disorder and service providers.

  • Based on products, the cell therapy instrument market is segmented into consumables, equipment, systems and software. The consumables segment held a larger market share in 2023.
  • By cell type, the cell therapy instrument market is segmented into human cells, animal cells. The thermoplastics segment held the largest share of the market in 2023.
  • By process, the cell therapy instrument market is segmented into cell processing, process monitoring and quality control, cell preservation, distribution, and handling. The cell processing segment held the largest share of the market in 2023.
  • By end users, the cell therapy instrument market is segmented into research institutes, life science research companies, other end users. The life science research companies segment held the largest share of the market in 2023.

Cell Therapy Instrument Market Share Analysis by Geography

The geographic scope of the cell therapy instrument market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

The US is the largest and fastest-growing market for cell therapy instruments. The market growth is attributed to increased R & D and the growing adoption of cell therapies such as gene, stem cell, and immune therapies. In addition, increasing support from the government is enhancing the growth of cell therapies, influencing the market's growth. For instance, the American Society of Gene & Cell Therapy (ASGCT), a public organization, provides memberships to scientists, physicians, professionals, and patient advocates engaged in gene and cell therapies. ASGCT aims to enhance knowledge, education, and awareness regarding the clinical application of cell and gene therapies.

Cell Therapy Instrument Market Report Scope

Report Attribute Details
Market size in 2021 US$ 15.15 Billion
Market Size by 2031 US$ 59.98 Billion
Global CAGR (2023 - 2031) 15.4%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product
  • Consumables
  • Equipment
  • Systems and Software; Cell Type
By Cell Type
  • Human Cells
  • Animal Cells
By Process
  • Cell Processing
  • Process Monitoring and Quality Control
  • Cell Preservation
  • Distribution
  • Handling
By End User
  • Research Institutes
  • Life Science Research Companies
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • Lonza
  • Cytiva (GE Healthcare Life Sciences)
  • Terumo Corporation
  • BD
  • Miltenyi Biotec
  • STEMCELL Technologies Inc.
  • Sartorius AG
  • Danaher Corporation (Beckman Coulter Inc.)
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Cell Therapy Instrument Market News and Recent Developments

    The cell therapy instrument market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for foot orthotic insoles:

    • Thermo Fisher Scientific and robotics expert Multiply Labs signed an agreement to further their collaboration to automate cell therapy production. (Source: Thermo Fisher Scientific, 2024).
    • To provide a unified technological platform for next-generation cellular therapies from concept to commercialization, MaxCyte launches the ExPERT instrument family. (Source: MaxCyte, Press Release, 2019).

    Cell Therapy Instrument Market Report Coverage and Deliverables

    The “Cell Therapy Instrument Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Product ; Cell Type ; Process ; End User , and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Trends and growth analysis reports related to Medical Device : READ MORE..